Trials / Conditions / Platinum-sensitive Relapsed Ovarian Cancer
Platinum-sensitive Relapsed Ovarian Cancer
4 registered clinical trials studyying Platinum-sensitive Relapsed Ovarian Cancer — 1 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Not Yet Recruiting | Adebrelimab Plus Chemotherapy, Bevacizumab and Fluzoparib in Platinum-Sensitive Relapsed Ovarian Cancer NCT06446206 | The First Hospital of Jilin University | Phase 2 |
| Unknown | Clinical Trial Evaluating the Efficacy and Safety of ZL-2306 (Niraparib) in Ovarian Cancer Patient NCT03705156 | Zai Lab (Shanghai) Co., Ltd. | Phase 3 |
| Withdrawn | Olaparib Maintenance Treatment Versus Placebo in Patients With PSR Ovarian Cancer Who Are in CR or PR to Plati NCT02392676 | AstraZeneca | Phase 3 |
| Terminated | Weekly Carboplatin and Taxotere in Platinum Sensitive Relapsed Ovarian or Tubal or Primary Peritoneal Cancers NCT00247988 | University of Saskatchewan | Phase 2 |